acamprosate calcium
acamprosate calcium is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including acamprosate calcium. Available dosage form: tablet, delayed release.
Drug details
- Generic Name
- acamprosate calcium
- Brand Names
- acamprosate calcium
- Application Number
- ANDA205995
- Sponsor
- REMEDYREPACK INC.
- NDC Codes
- 3
- Dosage Forms
- TABLET, DELAYED RELEASE
- Routes
- ORAL
- Active Ingredients
- ACAMPROSATE CALCIUM
Indications and Usage
1 INDICATIONS AND USAGE Acamprosate calcium is indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. Treatment with acamprosate calcium should be part of a comprehensive management program that includes psychosocial support. The efficacy of acamprosate calcium in promoting abstinence has not been demonstrated in subjects who have not undergone detoxification and not achieved alcohol abstinence prior to beginning acamprosate calcium treatment. The efficacy of acamprosate calcium in promoting abstinence from alcohol in polysubstance abusers has not been adequately assessed. Acamprosate calcium delayed-release tablets are indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation (1, 14). Treatment with acamprosate calcium delayed-release tablets should be part of a comprehensive management program that includes psychosocial support (1).